Anna Dubaniewicz

1.6k total citations
67 papers, 926 citations indexed

About

Anna Dubaniewicz is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Anna Dubaniewicz has authored 67 papers receiving a total of 926 indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Physiology, 20 papers in Pulmonary and Respiratory Medicine and 19 papers in Infectious Diseases. Recurrent topics in Anna Dubaniewicz's work include Sarcoidosis and Beryllium Toxicity Research (40 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (18 papers) and Tuberculosis Research and Epidemiology (17 papers). Anna Dubaniewicz is often cited by papers focused on Sarcoidosis and Beryllium Toxicity Research (40 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (18 papers) and Tuberculosis Research and Epidemiology (17 papers). Anna Dubaniewicz collaborates with scholars based in Poland, United States and United Kingdom. Anna Dubaniewicz's co-authors include Mirosława Dubaniewicz-Wybieralska, Mahavir Singh, Grażyna Moszkowska, Zofia Szczerkowska, Piotr Trzonkowski, Marlena Typiak, Andrzej Myśliwski, L Budohoski, Maria Dudziak and Barbara Lewko and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Biochemical Journal.

In The Last Decade

Anna Dubaniewicz

62 papers receiving 908 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Dubaniewicz Poland 17 545 327 272 209 208 67 926
Ross P. Walton United Kingdom 19 755 1.4× 359 1.1× 140 0.5× 485 2.3× 146 0.7× 31 1.5k
Juan R. Velázquez Mexico 15 233 0.4× 112 0.3× 112 0.4× 141 0.7× 96 0.5× 37 821
Daniel E. Dulek United States 16 219 0.4× 111 0.3× 141 0.5× 255 1.2× 92 0.4× 44 901
J Hull United Kingdom 12 204 0.4× 609 1.9× 113 0.4× 457 2.2× 193 0.9× 22 1.3k
Alanna Peterson United States 7 510 0.9× 140 0.4× 247 0.9× 226 1.1× 127 0.6× 9 1.3k
Vijay Mistry United Kingdom 17 1.1k 2.0× 1.1k 3.3× 81 0.3× 124 0.6× 202 1.0× 44 1.7k
Grzegorz Cieslewicz United States 13 812 1.5× 358 1.1× 57 0.2× 254 1.2× 69 0.3× 20 1.2k
P Tukiainen Finland 18 367 0.7× 753 2.3× 132 0.5× 322 1.5× 79 0.4× 55 1.1k
Takehito Kobayashi Japan 16 320 0.6× 167 0.5× 59 0.2× 58 0.3× 103 0.5× 56 707
Marcello Mariani Italy 15 166 0.3× 101 0.3× 99 0.4× 87 0.4× 117 0.6× 57 713

Countries citing papers authored by Anna Dubaniewicz

Since Specialization
Citations

This map shows the geographic impact of Anna Dubaniewicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Dubaniewicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Dubaniewicz more than expected).

Fields of papers citing papers by Anna Dubaniewicz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Dubaniewicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Dubaniewicz. The network helps show where Anna Dubaniewicz may publish in the future.

Co-authorship network of co-authors of Anna Dubaniewicz

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Dubaniewicz. A scholar is included among the top collaborators of Anna Dubaniewicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Dubaniewicz. Anna Dubaniewicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Typiak, Marlena, et al.. (2023). Comparative Analysis of FCGR Gene Polymorphism in Pulmonary Sarcoidosis and Tuberculosis. Cells. 12(9). 1221–1221. 4 indexed citations
2.
Dubaniewicz, Anna. (2023). Mycobacterial Heat Shock Proteins in Sarcoidosis and Tuberculosis. International Journal of Molecular Sciences. 24(6). 5084–5084. 9 indexed citations
3.
Kishore, Amit, Jana Petřková, Martina Doubková, et al.. (2023). Evaluation of genetic risk, its clinical manifestation and disease management based on 18 susceptibility gene markers among West-Slavonic patients with sarcoidosis. Gene. 878. 147577–147577. 1 indexed citations
4.
Clarke, Erik, Abigail Lauder, Casey E. Hofstaedter, et al.. (2017). Microbial Lineages in Sarcoidosis. A Metagenomic Analysis Tailored for Low–Microbial Content Samples. American Journal of Respiratory and Critical Care Medicine. 197(2). 225–234. 56 indexed citations
5.
Holas, Paweł, et al.. (2017). Association of anxiety sensitivity-physical concerns and FVC with dyspnea severity in sarcoidosis. General Hospital Psychiatry. 47. 43–47. 6 indexed citations
6.
Typiak, Marlena, Krzysztof Rębała, Maria Dudziak, & Anna Dubaniewicz. (2014). Polymorphism of FCGR3A gene in sarcoidosis. Human Immunology. 75(4). 283–288. 13 indexed citations
7.
Dubaniewicz, Anna. (2014). Heat shock proteins as 'danger signals' in sarcoidosis. European Respiratory Journal. 44(Suppl 58). P3790–P3790. 1 indexed citations
8.
Dubaniewicz, Anna. (2013). Microbial and human heat shock proteins as ‘danger signals’ in sarcoidosis. Human Immunology. 74(12). 1550–1558. 38 indexed citations
9.
Dubaniewicz, Anna, Agnieszka Zimmermann, Mirosława Dubaniewicz-Wybieralska, et al.. (2012). Sarcoidosis and Tuberculosis: A Connection to the Human Leukocyte Antigen System. Advances in experimental medicine and biology. 756. 229–237. 10 indexed citations
10.
Dubaniewicz, Anna. (2009). Sarkoidoza - choroba o wielu twarzach. 3(1). 27–41. 4 indexed citations
11.
Dubaniewicz, Anna. (2009). Mycobacterium tuberculosis heat shock proteins and autoimmunity in sarcoidosis. Autoimmunity Reviews. 9(6). 419–424. 60 indexed citations
12.
Kozłowski, Dariusz, Adam Kosiński, Anna Dubaniewicz, et al.. (2007). The morphological conditions of the permanent pacemaker lead extraction. Via Medica Journals. 48(4).
13.
14.
Dubaniewicz, Anna, et al.. (2007). DQA1*03011 allele: Protective or an adverse effect on the development of sarcoidosis; preliminary study. Respiratory Medicine. 101(10). 2213–2216. 4 indexed citations
15.
Dubaniewicz, Anna, Grażyna Moszkowska, & Zofia Szczerkowska. (2005). Frequency of DRB1–DQB1 two-locus haplotypes in tuberculosis: Preliminary report. Tuberculosis. 85(4). 259–267. 31 indexed citations
16.
Rzepko, Robert, et al.. (2005). Pregranulomatous phase of sarcoidosis: Immunohistochemical diagnosis. Acta Histochemica. 107(6). 473–477. 3 indexed citations
17.
Lewko, Barbara, Ewa Bryl, Jacek M. Witkowski, et al.. (2002). Effect of Angiotensin II on ANP-Dependent Guanylyl Cyclase Activity in Cultured Mouse and Rat Podocytes. Kidney & Blood Pressure Research. 25(5). 296–302. 15 indexed citations
18.
Kozłowski, Dariusz, Edward Koźluk, Anna Dubaniewicz, et al.. (2000). Morfologiczne aspekty jednojamowej prawokomorowej stałej stymulacji serca. Część II: Zmiany odczynowo-włóknikowe w aspekcie rozwoju niedomykalności trójdzielnej. Via Medica Journals. 7(2). 105–111. 1 indexed citations
19.
Dubaniewicz, Anna, et al.. (2000). Molecular subtypes of the HLA-DR antigens in pulmonary tuberculosis. International Journal of Infectious Diseases. 4(3). 129–133. 37 indexed citations
20.
Kozłowski, Dariusz, Anna Dubaniewicz, Edward Koźluk, et al.. (1998). Błędne interwencje lecznicze kardiowerterów- -defibrylatorów — nadal istotny problem kliniczny. Folia Cardiologica. 5(1). 38–44. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ross P. Walton Breakdown of academic impact, for papers by Juan R. Velázquez Breakdown of academic impact, for papers by Daniel E. Dulek Breakdown of academic impact, for papers by J Hull Breakdown of academic impact, for papers by Alanna Peterson Breakdown of academic impact, for papers by Vijay Mistry Breakdown of academic impact, for papers by Grzegorz Cieslewicz Breakdown of academic impact, for papers by P Tukiainen Breakdown of academic impact, for papers by Takehito Kobayashi Breakdown of academic impact, for papers by Marcello Mariani
Rankless by CCL
2026